Log in

NYSE:CFXColfax Stock Price, Forecast & News

$28.27
-0.43 (-1.50 %)
(As of 07/8/2020 04:00 PM ET)
Add
Compare
Today's Range
$28.04
Now: $28.27
$28.73
50-Day Range
$25.74
MA: $28.03
$32.47
52-Week Range
$12.23
Now: $28.27
$39.30
Volume724,000 shs
Average Volume1.14 million shs
Market Capitalization$3.35 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.84
Colfax Corporation operates as a diversified technology company worldwide. The company operates through Air and Gas Handling, and Fabrication Technology segments. The Air and Gas Handling segment designs, manufactures, installs, and maintains heavy-duty fans, rotary heat exchangers, blowers, and compressors. It markets air and gas handling products under the Howden brand name. This segment sells its products and services directly, as well as through independent representatives and distributors to customers in the power generation, oil, gas and petrochemical, mining, wastewater, general industrial, and other markets. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding of steels, aluminum, and other metals and metal alloys. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips under the ESAB brand name. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine, pipelines, mobile/off-highway equipment, oil, gas, and mining markets. Colfax Corporation was founded in 1860 and is headquartered in Annapolis Junction, Maryland.
Read More
Colfax logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 2.5 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.60 out of 5 stars


Industry, Sector and Symbol

Industry Pumps & pumping equipment
Sub-IndustryIndustrial Machinery
CUSIP19401410
Phone301-323-9000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$3.33 billion
Cash Flow$4.64 per share
Book Value$29.63 per share

Profitability

Net Income$-527,650,000.00

Miscellaneous

Employees15,000
Market Cap$3.35 billion
Next Earnings Date8/4/2020 (Estimated)
OptionableOptionable

Receive CFX News and Ratings via Email

Sign-up to receive the latest news and ratings for CFX and its competitors with MarketBeat's FREE daily newsletter.

Colfax (NYSE:CFX) Frequently Asked Questions

How has Colfax's stock been impacted by COVID-19 (Coronavirus)?

Colfax's stock was trading at $25.64 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CFX stock has increased by 10.3% and is now trading at $28.27. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Colfax?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colfax in the last year. There are currently 1 sell rating, 4 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Colfax.

When is Colfax's next earnings date?

Colfax is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Colfax.

How were Colfax's earnings last quarter?

Colfax Corp (NYSE:CFX) released its earnings results on Thursday, May, 7th. The industrial products company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.01. The industrial products company had revenue of $816.40 million for the quarter, compared to analyst estimates of $790.17 million. Colfax had a positive return on equity of 8.89% and a negative net margin of 13.62%. The business's revenue for the quarter was down 19.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.53 earnings per share. View Colfax's earnings history.

What price target have analysts set for CFX?

17 brokers have issued 12 month price objectives for Colfax's shares. Their forecasts range from $9.00 to $50.00. On average, they anticipate Colfax's share price to reach $29.56 in the next twelve months. This suggests a possible upside of 4.6% from the stock's current price. View analysts' price targets for Colfax.

Has Colfax been receiving favorable news coverage?

News stories about CFX stock have been trending negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Colfax earned a daily sentiment score of -2.1 on InfoTrie's scale. They also gave news coverage about the industrial products company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news about Colfax.

Who are some of Colfax's key competitors?

What other stocks do shareholders of Colfax own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Colfax investors own include Endologix (ELGX), Apache (APA), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), AutoZone (AZO), Charles Schwab (SCHW), Accenture (ACN), UMB Financial (UMBF), Agree Realty (ADC) and Gran Tierra Energy (GTE).

Who are Colfax's key executives?

Colfax's management team includes the following people:
  • Mr. Mitchell P. Rales, Co-Founder & Chairman (Age 62)
  • Mr. Matthew L. Trerotola, Pres, CEO & Director (Age 52)
  • Mr. Christopher M. Hix, Sr. VP of Fin., CFO & Treasurer (Age 57)
  • Mr. Daniel A. Pryor, Exec. VP of Strategy & Bus. Devel. (Age 51)
  • Mr. Shyam Kambeyanda, Sr. VP (Age 48)

What is Colfax's stock symbol?

Colfax trades on the New York Stock Exchange (NYSE) under the ticker symbol "CFX."

Who are Colfax's major shareholders?

Colfax's stock is owned by many different institutional and retail investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.03%) and Nelson Van Denburg & Campbell Wealth Management Group LLC (0.02%). Company insiders that own Colfax stock include A Lynne Puckett, Christopher M Hix, Daniel A Pryor, Douglas J Pitts, Ian Brander, Jason Maclean, Liam Kelly, Lynn H Clark, Matthew L Trerotola, Rajiv Vinnakota and Shyam Kambeyanda. View institutional ownership trends for Colfax.

Which institutional investors are selling Colfax stock?

CFX stock was sold by a variety of institutional investors in the last quarter, including Nelson Van Denburg & Campbell Wealth Management Group LLC, and Envestnet Asset Management Inc.. Company insiders that have sold Colfax company stock in the last year include Christopher M Hix, Daniel A Pryor, Douglas J Pitts, Matthew L Trerotola, Rajiv Vinnakota, and Shyam Kambeyanda. View insider buying and selling activity for Colfax.

How do I buy shares of Colfax?

Shares of CFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Colfax's stock price today?

One share of CFX stock can currently be purchased for approximately $28.27.

How big of a company is Colfax?

Colfax has a market capitalization of $3.35 billion and generates $3.33 billion in revenue each year. The industrial products company earns $-527,650,000.00 in net income (profit) each year or $2.33 on an earnings per share basis. Colfax employs 15,000 workers across the globe.

What is Colfax's official website?

The official website for Colfax is www.colfaxcorp.com.

How can I contact Colfax?

Colfax's mailing address is 420 NATIONAL BUSINESS PARKWAY 5TH FLOOR, ANNAPOLIS JUNCTION MD, 20701. The industrial products company can be reached via phone at 301-323-9000.

This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.